The modifier effect of the BDNF gene in the phenotype of the WAGRO syndrome

Gene

Volumn 516, Issue 2, 2013, Pages 285-290

  Rodríguez López, Raquel ^a   Pérez, José M Carbonell ^a   Balsera, Aránzazu Margallo ^a   Rodríguez, Guillermo Gervasini ^b   Moreno, Trinidad Herrera ^a   García de Cáceres, Mayte ^a   Serrano, Marta González Carpio ^a   Freijo, Felipe Casanueva ^c   Ruiz, Juan Ramón González ^d   Angueira, Francisco Barros ^e   Pérez, Pilar Méndez ^a   Estévez, Manuela Núñez ^a   Gómez, Enrique Galán ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

BDNF; Obesity; SNP CNV array; WAGRO

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

AMINO ACID SUBSTITUTION; ANIRIDIA; ARTICLE; BODY MASS; CASE REPORT; CHILD; CHILDHOOD OBESITY; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; ENERGY BALANCE; EXON; FEMALE; FOOD INTAKE; GENE DELETION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOINSUFFICIENCY; HUMAN; MENTAL DEFICIENCY; NEPHROBLASTOMA; NERVE CELL PLASTICITY; OPEN READING FRAME; PHENOTYPE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UROGENITAL TRACT MALFORMATION; WAGRO SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; GENES, MODIFIER; HUMANS; KARYOTYPE; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; WAGR SYNDROME; YOUNG ADULT;

EID: 84873268370     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.073     Document Type: Article

References (21)

1. Bamiou D.E., et al. Auditory interhemispheric transfer deficits, hearing difficulties, and brain magnetic resonance imaging abnormalities in children with congenital aniridia due to PAX6 mutations. Arch. Pediatr. Adolesc. Med. 2007, 161:463-469.
2. Clericuzio C., Hingorani M., Crolla J.A., van Heyningen V., Verloes A. Clinical utility gene card for: WAGR syndrome. Eur. J. Hum. Genet. 2011, 19:4.
3. Cordeira J.W., Frank L., Sena-Esteves M., Pothos E.N., Rios M. Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J. Neurosci. 2010, 30:2533-2541.
4. Egan M.F., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
5. Fischbach B.V., Trout K.L., Lewis J., Luis C.A., Sika M. WAGR syndrome: a clinical review of 54 cases. Pediatrics 2005, 116:984-988.
6. González J.R., et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007, 23:644-645.
7. Gray J., et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006, 55:3366-3371.
8. Han J.C., et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N. Engl. J. Med. 2008, 359:918-927.
9. Kim J., Lauderdale J.D. Analysis of Pax6 expression using a BAC transgene reveals the presence of a paired-less isoform of Pax6 in the eye and olfactory bulb. Dev. Biol. 2006, 15:486-505.
10. Kleinjan D.A., et al. Long-range downstream enhancers are essential for Pax6 expression. Dev. Biol. 2006, 15:563-581.
11. Lauderdale J.D., Wilensky J.S., Oliver E.R., Walton D.S., Glaser T. 3' deletions cause aniridia by preventing PAX6 gene expression. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13755-13759.
12. Lin C.H., Wu R.M., Tai C.H., Chen M.L., Hu F.C. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease. Parkinsonism Relat. Disord. 2011, 17:84-88.
13. Liu J., Zhou Y., Wang C., Wang T., Zheng Z., Chan P. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease. Parkinsonism Relat. Disord. 2012, 18:140-143.
14. Malandrini A., et al. PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation. Clin. Genet. 2001, 60:151-154.
15. Monteggia L.M., et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10827-10832.
16. Shinawi M., et al. 11p14.1 microdeletions associated with ADHD, autism, developmental delay, and obesity. Am. J. Med. Genet. A 2011, 6:1272-1280.
17. Terracciano A., et al. Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study. World J. Biol. Psychiatry 2011, (Epub ahead of print).
18. Tzoulaki I., White I.M., Hanson I.M. PAX6 mutations: genotype phenotype correlations. BMC Genet. 2005, 6:27.
19. van Heyningen V., Williamson K.A. PAX6 in sensory development. Hum. Mol. Genet. 2002, 11:1161-1167.
20. van Heyningen V., Hoovers J.M., de Kraker J., Crolla J.A. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion. J. Med. Genet. 2007, 44:787-790.
21. Xu S., Han J.C., Morales A., Menzie C.M., Williams K., Fan Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122:181-187.